"Previous studies by Katz and colleagues showed low-dose ketamine to reverse deficits in brain activity in mouse models of Rett syndrome, while also significantly improving neurologic function, including breathing."
Δευτέρα, 9 Μαρτίου 2015
Rett Syndrome Research Trust Awards $1.3 Million for Low-Dose Ketamine Phase 2 Trial
Rett Syndrome Research Trust Awards $1.3 Million for Low-Dose Ketamine Phase 2 Trial
"Previous studies by Katz and colleagues showed low-dose ketamine to reverse deficits in brain activity in mouse models of Rett syndrome, while also significantly improving neurologic function, including breathing."
"Previous studies by Katz and colleagues showed low-dose ketamine to reverse deficits in brain activity in mouse models of Rett syndrome, while also significantly improving neurologic function, including breathing."
Εγγραφή σε:
Σχόλια ανάρτησης
(
Atom
)
Δεν υπάρχουν σχόλια :
Δημοσίευση σχολίου